153 related articles for article (PubMed ID: 38287007)
1. Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma.
Liu Z; Zhang Z; Zhang Y; Zhou W; Zhang X; Peng C; Ji T; Zou X; Zhang Z; Ren Z
Int J Oral Sci; 2024 Jan; 16(1):9. PubMed ID: 38287007
[TBL] [Abstract][Full Text] [Related]
2. Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-β/Smad pathway.
Yang W; Zhang S; Li T; Zhou Z; Pan J
Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 55(2):262-273. PubMed ID: 36148955
[TBL] [Abstract][Full Text] [Related]
3. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.
Zhi Y; Wang Q; Zi M; Zhang S; Ge J; Liu K; Lu L; Fan C; Yan Q; Shi L; Chen P; Fan S; Liao Q; Guo C; Wang F; Gong Z; Xiong W; Zeng Z
Adv Sci (Weinh); 2024 Mar; 11(12):e2306515. PubMed ID: 38229179
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
5. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-23 receptor defines T helper 1-like regulatory T cells in oral squamous cell carcinoma.
Li W; An N; Wang M; Liu X; Mei Z
Immun Inflamm Dis; 2022 Dec; 10(12):e746. PubMed ID: 36444617
[TBL] [Abstract][Full Text] [Related]
7. Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma.
Kondo Y; Suzuki S; Takahara T; Ono S; Goto M; Miyabe S; Sugita Y; Ogawa T; Ito H; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
Cancer Sci; 2021 Oct; 112(10):4037-4049. PubMed ID: 34309966
[TBL] [Abstract][Full Text] [Related]
8. Role of tissue markers associated with tumor microenvironment in the progression and immune suppression of oral squamous cell carcinoma.
Ramalingam S; Shantha S; Muralitharan S; Sudhakar U; Thamizhchelvan H; Parvathi VD
Med Oncol; 2023 Sep; 40(10):303. PubMed ID: 37731058
[TBL] [Abstract][Full Text] [Related]
9. Single-Cell Profiling Reveals Heterogeneity of Primary and Lymph Node Metastatic Tumors and Immune Cell Populations and Discovers Important Prognostic Significance of CCDC43 in Oral Squamous Cell Carcinoma.
Wang Z; Zhang H; Zhai Y; Li F; Shi X; Ying M
Front Immunol; 2022; 13():843322. PubMed ID: 35401551
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
11. Differential OAT methylation correlates with cell infiltration in tumor microenvironment and overall survival postradiotherapy in oral squamous cell carcinoma patient.
Sun Y; Yang J; Cai H; Liu J; Liu Y; Luo J; Zhou H
J Oral Pathol Med; 2022 Aug; 51(7):611-619. PubMed ID: 35708285
[TBL] [Abstract][Full Text] [Related]
12. Influence of tumor cell-derived TGF-β on macrophage phenotype and macrophage-mediated tumor cell invasion.
Maldonado LAG; Nascimento CR; Rodrigues Fernandes NA; Silva ALP; D'Silva NJ; Rossa C
Int J Biochem Cell Biol; 2022 Dec; 153():106330. PubMed ID: 36343916
[TBL] [Abstract][Full Text] [Related]
13. Oral squamous cell carcinoma-derived EVs promote tumor progression by regulating inflammatory cytokines and the IL-17A-induced signaling pathway.
Li R; Zhou Y; Zhang M; Xie R; Duan N; Liu H; Qin Y; Ma J; Li Z; Ye P; Wang W; Wang X
Int Immunopharmacol; 2023 May; 118():110094. PubMed ID: 37030119
[TBL] [Abstract][Full Text] [Related]
14. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.
Peng Y; Yin D; Li X; Wang K; Li W; Huang Y; Liu X; Ren Z; Yang X; Zhang Z; Zhang S; Fan T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6097-6113. PubMed ID: 36656379
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the effect of CCR7 on the microenvironment of mouse oral squamous cell carcinoma by single-cell RNA sequencing technology.
Wang Z; Kirkwood KL; Wang Y; Du W; Lin S; Zhou W; Yan C; Gao J; Li Z; Sun C; Liu F
J Exp Clin Cancer Res; 2024 Mar; 43(1):94. PubMed ID: 38539232
[TBL] [Abstract][Full Text] [Related]
16. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma.
Wang X; Zhang J; Zhou G
J Oral Pathol Med; 2021 Apr; 50(4):362-370. PubMed ID: 33187013
[TBL] [Abstract][Full Text] [Related]
17. Role of Stromal Fibroblast-Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma.
Kayamori K; Katsube KI; Hirai H; Harada H; Ikeda T
Lab Invest; 2023 Oct; 103(10):100228. PubMed ID: 37541622
[TBL] [Abstract][Full Text] [Related]
18. Stromal-epithelial lactate shuttle induced by tumor‑derived interleukin‑1β promotes cell proliferation in oral squamous cell carcinoma.
Wu J; Hong Y; Wu T; Wang J; Chen X; Wang Z; Cheng B; Xia J
Int J Mol Med; 2018 Feb; 41(2):687-696. PubMed ID: 29207019
[TBL] [Abstract][Full Text] [Related]
19. F. nucleatum facilitates oral squamous cell carcinoma progression via GLUT1-driven lactate production.
Sun J; Tang Q; Yu S; Xie M; Zheng W; Chen G; Yin Y; Huang X; Wo K; Lei H; Zhang J; Wan Q; Chen L
EBioMedicine; 2023 Feb; 88():104444. PubMed ID: 36709580
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic genes in oral squamous cell carcinoma microenvironment.
Zhu L; Zhang X; Chen Y; Yan D; Han J
Cancer Biomark; 2022; 34(4):523-532. PubMed ID: 35275524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
